Freeflow Ventures
Funding rounds backed by Freeflow Ventures.
- Funding disclosed in full
- $18.2M
- Median round
- $4.5M
- Rounds in calculation
- 3
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| TippingPoint Biosciences Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5MSeed | BiotechUnited States | |||
| Sift Biosciences Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7MPre-Seed | BiotechUnited States | |||
| Vivere Oncotherapies Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t... | $10MSeries A | BiotechUnited States |